All Comments by Benjamin Wolozin

  1. Alzheimer's disease: model behaviour.
  2. Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep.
  3. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients.
  4. The intracellular domain of the beta-amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-like manner.
  5. Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis.
  6. Identification of estrogen target genes in human neural cells.
  7. Estrogen lowers Alzheimer beta-amyloid generation by stimulating trans-Golgi network vesicle biogenesis.
  8. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people.
  9. Susceptibility locus for Alzheimer's disease on chromosome 10.
  10. Oxidative stress induces intracellular accumulation of amyloid beta-protein (Abeta) in human neuroblastoma cells.
  11. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
  12. Imaging brain amyloid of Alzheimer disease in vivo in transgenic mice with an Abeta peptide radiopharmaceutical.
  13. Protein kinase C regulation of intracellular and cell surface amyloid precursor protein (APP) cleavage in CHO695 cells.
  14. Distinct Ca2+ thresholds determine cytochrome c release or permeability transition pore opening in brain mitochondria.
  15. Presenilin-1 mutations in Alzheimer's disease.